Dysregulated cell death occurs in many human diseases, and modulating the associated pathways has proved effective in the treatment of cancer, stroke and neurodegenerative disorders. In their review, Kepp and colleagues provide an overview of assays capable of accurately quantifying distinct cell death pathways, focusing on those techniques that are applicable to high-throughput screening.
- Oliver Kepp
- Lorenzo Galluzzi
- Guido Kroemer
